Recurrent Device Thrombi During Mechanical Circulatory Support With an Axial-flow Pump Is a Treatable Condition and Does Not Preclude Successful Long-term Support

2007 ◽  
Vol 26 (2) ◽  
pp. 200-203 ◽  
Author(s):  
Jama Jahanyar ◽  
George P. Noon ◽  
Michael M. Koerner ◽  
Keith A. Youker ◽  
S. Chris Malaisrie ◽  
...  
ASAIO Journal ◽  
2015 ◽  
Vol 61 (2) ◽  
pp. 196-201 ◽  
Author(s):  
Xufeng Wei ◽  
Pablo G. Sanchez ◽  
Yang Liu ◽  
Tieluo Li ◽  
A. Claire Watkins ◽  
...  

2020 ◽  
Author(s):  
Navin K Kapur ◽  
Michele L Esposito ◽  
Evan Whitehead

Use of short-term mechanical circulatory support pumps for cardiogenic shock, decompensated heart failure and high-risk coronary intervention is growing. The Aortix™ device (Procyrion, TX, USA) is the first axial-flow pump positioned in the aorta and is designed to provide short-term hemodynamic support. This review discusses the field of continuous flow aortic pumps and focuses specifically on emerging preclinical and clinical data supporting the development of these technologies.


ASAIO Journal ◽  
2004 ◽  
Vol 50 (2) ◽  
pp. 146
Author(s):  
M Kindo ◽  
B Radovancevic ◽  
J L Conger ◽  
I G Gregoric ◽  
K A Kadipasaoglu ◽  
...  
Keyword(s):  

2008 ◽  
Vol 20 (2) ◽  
pp. 124-127 ◽  
Author(s):  
Hiroaki Konishi ◽  
James F. Antaki ◽  
Philip Litwak ◽  
Marina Kameneva ◽  
Kenji Yamazaki ◽  
...  

2005 ◽  
Vol 26 (10) ◽  
pp. 1031-1038 ◽  
Author(s):  
Michael P. Siegenthaler ◽  
Stephen Westaby ◽  
O.H. Frazier ◽  
Jürgen Martin ◽  
Adrian Banning ◽  
...  

2021 ◽  
Vol 12 (4) ◽  
pp. 542-546
Author(s):  
Gianluigi Perri ◽  
Matteo Trezzi ◽  
Roberto Formigari ◽  
Rachele Adorisio ◽  
Sergio Filippelli ◽  
...  

An alternative strategy for left ventricular (LV) venting during short-term mechanical circulatory support is use of Impella axial-flow pump. We present our transcarotid Impella 2.5 implantation technique using a polytetrafluoroethylene graft, in two children with acute heart failure treated primarily with venoarterial ECMO. The venoarterial extracorporeal membrane oxygenator and Impella support were maintained for 5 and 17 days, respectively. Transcarotid Impella implantation might be an alternative and feasible option in pediatrics patients affected by severe LV failure, as a bridge to decision or bridge to candidacy. Potentially, the Impella 2.5 device provides less invasive support for children with heart failure.


2018 ◽  
Vol 37 (7) ◽  
pp. 933-936 ◽  
Author(s):  
Marian Urban ◽  
Anfrew Woods ◽  
Nicola Robinson-Smith ◽  
Guy MacGowan ◽  
Chandrika Roysam ◽  
...  

2008 ◽  
Vol 7 ◽  
pp. 173-173
Author(s):  
A GKOUZIOUTA ◽  
E LEONTIADIS ◽  
S ADAMOPOULOS ◽  
A MANGINAS ◽  
G KARAVOLIAS ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document